HCMNY
ABBV icon

Howard Capital Management (New York)’s AbbVie ABBV Stock Holding History

Howard Capital Management (New York)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,000
Closed -$282K – 96
2014
Q2 		$282K Buy
+5,000
New +$262K 0.06% 87

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Howard Capital Management (New York)'s ABBV Position: Q3 2014 in Review

Howard Capital Management (New York) sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 5,000 shares — an estimated $282K sold.

Howard Capital Management (New York) first reported a position in ABBV in Q2 2014 and held it in 1 quarter. The position peaked at $282K in Q2 2014. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Howard Capital Management (New York) reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
  • Howard Capital Management (New York) sold 5,000 AbbVie shares in Q3 2014, an estimated $282K.
  • Howard Capital Management (New York) first reported a position in AbbVie in Q2 2014 and held it in 1 quarter.
  • Howard Capital Management (New York)'s AbbVie position peaked at $282K in Q2 2014.
  • 1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Howard Capital Management (New York)'s 13F filing for Q3 2014, filed 20 Oct 2014.